Potent cannabis linked to surging schizophrenia cases - New schizophrenia cases linked to cannabis use disorder more than ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The North Chicago-based drugmaker is relying on newer treatments to make up for falling sales of Humira, its aging ...

Despite finishing strong across both its innovative and generic businesses in 2024, Teva’s cautious approach to the new year ...

which can lead to long delays in starting the drug, Taipale and colleagues observed. "When a person with first-episode schizophrenia has a first psychosis relapse despite the use of non-clozapine ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.